Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540618 · ClinicalTrials.gov registry record · Phase 2
A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis
A Phase 2 study, sponsored by MedImmune.
- Completed
- Registry status
- Phase 2
- Development phase
- 420
- Enrollment target
NCT00540618 is a Phase 2 study that has completed, run by MedImmune. The registered enrollment target is 420 participants.
The verdict
NCT00540618, a Phase 2 study, has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 420 participants
- Enrollment target
Study Summary
To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.
Interventions
- OTHER Placebo
- DRUG MEDI-507
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2001-09 |
| Est. Completion | 2003-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00540618
The ClinicalTrials.gov registry entry for NCT00540618 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 420 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedImmune, which has 210 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00540618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00540618 about?
NCT00540618 is a clinical study titled "A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis". To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.
What is the current status of trial NCT00540618?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 420 participants. The study started on 2001-09. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00540618?
The interventions under investigation include: Placebo (OTHER), MEDI-507 (DRUG).
Who is sponsoring clinical trial NCT00540618?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.